LUCIRA HEALTH INST023 COVID-19 Test Kit User Guide
- June 6, 2024
- LUCIRA HEALTH
Table of Contents
LUCIRA HEALTH INST023 COVID-19 Test Kit User Guide
Test only works if you follow each step Open for instructions
Indication
The Lucira CHECK√IT COVID-19 Test Kit is a single-use test kit intended to detect the novel corona virus SARS-CoV-2 that causes COVID-19. This test is authorized for nonprescription over-the-counter (OTC) use with self-collected nasal swab samples in individuals 14 years and older (self-collected) or individuals ≥2 years (collected by an adult) with or without symptoms or other epidemiological reasons to suspect COVID-19. This test is similar to a PCR test in that it utilizes a molecular amplification technology for the detection of SARS-CoV-2 RNA.
Positive results are indicative of the presence of SARS-CoV-2. Individuals who test positive should self-isolate and seek additional care from their healthcare provider. Positive results do not rule out bacterial infection or confection with other viruses.
Negative results do not preclude SARS-CoV-2 infection. Individuals who test negative and continue to experience COVID-like symptoms should seek follow up care from a healthcare provider. Negative results in an asymptomatic individual are presumptive and confirmation with a molecular assay performed in a laboratory, if necessary for patient management, may be performed.
The Lucira CHECK√IT COVID-19 Test Kit is for use only under the Food and Drug Administration’s Emergency Use Authorization.
Description
his Lucira CHECK√IT COVID-19 Test Kit contains everything needed to perform one (1) Lucira COVID-19 test: Instructions, 2 AA Batteries, 1 test unit, 1 sample vial, 1 sterile nasal swab and 1 disposal bag. For this test to work properly, it is important to read the instructions and follow each step.
Start Here
- Do not insert batteries or open test kit pouches until ready to perform test
- Choose a location to do this test where it can sit UNDISTURBED for 30 minutes.
- Please read all instructions carefully before you begin.
- Make sure your test kit contains: 2 AA batteries, test unit (pouch 1), sample vial (pouch 2), swab (labeled 3), and plastic disposal bag.
- Wash and dry hands.
Set Up Your Test
- When ready to begin test, open test unit pouch 1.
Open battery door and insert batteries. Check that Ready light is on.
- Open sample vial pouch 2
REMOVE sample vial seal
then GENTLY set in test unit but do NOT push the vial down.
- Do not open swab until ready to use.
Swab Both Nostrils
For this test to work properly, it is important you swab BOTH nostrils.
-
Remove swab and hold with handle end.
Do not set swab down. -
Tilt head back and gently insert swab tip until it is fully inside your nostril and you meet resistance.
-
Once swab tip is fully inside nostril, r oll the swab 5 times around the inside walls of your nostril. The swab should be touching the walls of the nostril as you rotate.
-
Repeat swab step in other nostril.
Rotate 5x in BOTH nostrils.
Make sure to roll around inside walls to collect a good sample.
Adults must swab children ages 2-13.
Stir Swab and Run Test
-
Insert swab into the sample vial until it touches the bottom.
-
Mix sample by stirring around the sample vial 15 times.
-
Discard swab.
-
Snap cap closed and press vial down into test unit until it clicks.
-
Ready light will start blinking when test is running.
If Ready light is not blinking within 5 seconds, use palm of your hand to press down more firmly to start test.
- Do not move test unit once the test has started running.
- Wait 30 minutes.
Read Result
Test will be ready in 30 minutes.
Done light will display when test is finished.
If you receive an Invalid result, please email us at cs@lucirahealth.com and we will assist you.
If you test POSITIVE
It is very likely you have COVID-19 and it is important to be under the care of a healthcare provider. It is likely you will be asked to isolate yourself at home to avoid spreading the virus to others. There is a very small chance that this test can give a positive result that is wrong (a false positive). Your healthcare provider will work with you to determine how best to care for you based on your test results along with medical history and your symptoms.
If you test NEGATIVE
A negative result means the virus that causes COVID-19 was not found in your sample. However, it is possible for this test to give a negative result that is incorrect (a false negative) in some people with COVID-19. This means you could possibly still have COVID-19 even though the test is negative. If this is the case, your healthcare provider will consider the test result with all other aspects of your history such as symptoms and possible exposures to decide how to care for you. It is important you work with your healthcare provider to help you understand the next steps you should take.
-
Swab
-
**Stir
**
- Detec t
The Lucira CHECK √ IT COVID-19 Test Kit is for FDA Emergency Use Authorization (EUA) only
For Over-The-Counter (OTC) Use
For In Vitro Diagnostic (IVD) Use
- This OTC test kit has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA.
- This OTC test kit has been authorized only for the testing of nasal swabs for detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens.
- The emergency use of this OTC test kit is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
- For more information on EUAs go here: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergencyuse-authorization
For the most up to date information on COVID-19, please visit: www.cdc.gov/COVID19
Frequently Asked Questions
- Will this test hurt? No, the nasal swab is not sharp and it should not hurt. Sometimes the swab can feel slightly uncomfortable or thickly.
- What tips will help me use the nasal swab correctly?
- How do I make sure I am getting a good sample?
Collecting a good sample requires rolling or rubbing the swab around the inside walls of both nostrils. Making sure you are touching the inside walls of the nostrils is very important.
Rotating the swab 5 times around the inside walls of both nostrils is very important for the test to work properly.
-
What are the known and potential risks and benefits of this test?
Potential risks include:- Possible discomfort during sample collection.
- Possible incorrect test results. Potential benefits include:
- The results, along with other information, can help your healthcare provider make informed recommendations about your care.
- The results of this test may help limit the spread of COVID-19 to your family and others in your community.
You have the option to refuse this test. However, your doctor has prescribed this test because they believe it could help with your care.
-
What if the display shows an invalid test result?
This means something with the test did not work properly.
If your test is invalid, all the lights will be blinking when the test is done in 30 minutes. If your test shows an invalid result, please email us at cs@lucirahealth.com and we will assist you. -
What is PCR quality molecular accuracy?
Lucira is a molecular test that amplifies the virus’s genetic material while the test is running just like PCR lab tests. Lucira’s amplification method provides a level of accuracy comparable to one of the highest sensitivity lab PCR tests. -
How accurate is this test?
Lucira’s CHECK√IT COVID-19 Test Kit is a molecular in vitro diagnostic test that has an analytical sensitivity, or ability to detect the SARS-CoV-2 virus, that is comparable to some of the best molecular PCR tests performed in clinical settings and high complexity labs.
In two Community Testing Studies which included 404 individuals with and without COVID-19 symptoms, the Lucira test achieved 98% (267/272) negative percent agreement (NPA) when compared to a FDA authorized known high sensitivity SARS-CoV-2 PCR test. Positive percent agreement (PPA) among symptomatic individuals was 94% and 90% in asymptomatic. Total PPA was 92% (121/132) across all samples and included 10 samples with very low levels of virus >37.5 Ct as shown below.
Lucira Community Testing Study Positive Percent Agreement (PPA) Summary
Samples shown by decreasing amount of virus
The # of cycles (CTs) required to detect virus increases when the amount of
virus in the sample is low
The above graph shows the Lucira CHECK√IT COVID-19 Test Kit positive percent
agreement in Lucira’s two Community Testing Studies. BLUE bars represent
samples where the Lucira positive test result matched the comparison test
result. GREY bars represent the Lucira test results that were negative and did
not match the comparison test positive result. Nearly all of the GREY bars
occurred in samples where there were very low levels of virus detected by the
comparison test.
1. La Scola B., Clinical Infectious Diseases, September 2020
For more information about Lucira’s clinical data, visit www.lucirahealth.com/data
Dispose of Test Kit
After test is completed, place the test unit in plastic disposal bag and dispose all test kit materials in trash.
Customer Support
For detailed instructions, visit: www.lucirahealth.com/Taiwan/IFU
Lucira Health, Inc. 1412 62nd Street Emeryville, California 94608, United States Package Insert (PI) INST023 Rev. 1
Read User Manual Online (PDF format)
Read User Manual Online (PDF format) >>